DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia
Clinical trial NCT04775953 · COMPLETED
Trial details
- NCT number
- NCT04775953
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-22
- Primary completion
- 2023-10-06
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.